Citations (136)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Pamela A. Lochhead, Jonathan Clark, Lan-Zhen Wang, Lesley Gilmour, Matthew Squires, Rebecca Gilley, Caroline Foxton, David R. Newell, Stephen R. Wedge & Simon J. Cook. (2016) Tumor cells with KRAS or BRAF mutations or ERK5/MAPK7 amplification are not addicted to ERK5 activity for cell proliferation. Cell Cycle 15:4, pages 506-518.
Read now
Read now
Maria Angulo-Ibáñez, Xavier Rovira-Clavé, Alba Granados-Jaén, Bradley Downs, Yeong C Kim, San Ming Wang, Manuel Reina & Enric Espel. (2015) Erk5 contributes to maintaining the balance of cellular nucleotide levels and erythropoiesis. Cell Cycle 14:24, pages 3864-3876.
Read now
Read now
Susana Hernández-García, Verena González, Eduardo Sanz & Atanasio Pandiella. (2015) Effect of Oncoxin Oral Solution in HER2-Overexpressing Breast Cancer. Nutrition and Cancer 67:7, pages 1159-1169.
Read now
Read now
Tatiana Erazo, Ana Moreno, Gerard Ruiz-Babot, Arantza Rodríguez-Asiain, Nicholas A. Morrice, Josep Espadamala, Jose R. Bayascas, Nestor Gómez & Jose M. Lizcano. (2013) Canonical and Kinase Activity-Independent Mechanisms for Extracellular Signal-Regulated Kinase 5 (ERK5) Nuclear Translocation Require Dissociation of Hsp90 from the ERK5-Cdc37 Complex. Molecular and Cellular Biology 33:8, pages 1671-1686.
Read now
Read now
Kunio Kondoh, Kazuya Terasawa, Hiroko Morimoto & Eisuke Nishida. (2006) Regulation of Nuclear Translocation of Extracellular Signal-Regulated Kinase 5 by Active Nuclear Import and Export Mechanisms. Molecular and Cellular Biology 26:5, pages 1679-1690.
Read now
Read now
Articles from other publishers (131)
Sheila Almaraz Postigo & Juan Carlos Montero. (2023) Neuregulin modulates hormone receptor levels in breast cancer through concerted action on multiple signaling pathways. Clinical Science 137:1, pages 1-15.
Crossref
Crossref
Juan Carlos Montero, Elisa Calvo-Jiménez, Sofía del Carmen, Mar Abad, Alberto Ocaña & Atanasio Pandiella. (2022) Surfaceome analyses uncover CD98hc as an antibody drug-conjugate target in triple negative breast cancer. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Crossref
Inchul You, Katherine A. Donovan, Noah M. Krupnick, Andrew S. Boghossian, Matthew G. Rees, Melissa M. Ronan, Jennifer A. Roth, Eric S. Fischer, Eric S. Wang & Nathanael S. Gray. (2022) Acute pharmacological degradation of ERK5 does not inhibit cellular immune response or proliferation. Cell Chemical Biology 29:11, pages 1630-1638.e7.
Crossref
Crossref
Nora Diéguez-Martínez, Sergio Espinosa-Gil, Guillermo Yoldi, Elisabet Megías-Roda, Idoia Bolinaga-Ayala, Maria Viñas-Casas, Gokhan Gorgisen, Inés Domingo-Ortí, Héctor Pérez-Montoyo, Jose R. Bayascas, Eva Colas, Xavier Dolcet & Jose M. Lizcano. (2022) The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival. Cellular and Molecular Life Sciences 79:10.
Crossref
Crossref
Elena Arconada-Luque, Jaime Jiménez-Suarez, Raquel Pascual-Serra, Syong Hyun Nam-Cha, Teresa Moline, Francisco J. Cimas, Germán Fliquete, Marta Ortega-Muelas, Olga Roche, Diego M. Fernández-Aroca, Raúl Muñoz Velasco, Natalia García-Flores, Cristina Garnés-García, Adrián Sánchez-Fdez, Sofía Matilla-Almazán, Víctor J. Sánchez-Arévalo Lobo, Javier Hernández-Losa, Borja Belandia, Atanasio Pandiella, Azucena Esparís-Ogando, Santiago Ramón y Cajal, Luis del Peso, Ricardo Sánchez-Prieto & María José Ruiz-Hidalgo. (2022) ERK5 Is a Major Determinant of Chemical Sarcomagenesis: Implications in Human Pathology. Cancers 14:14, pages 3509.
Crossref
Crossref
Laura Díaz-Gil, Fara Brasó-Maristany, Claudriana Locatelli, Ariana Centa, Balász Győrffy, Alberto Ocaña, Aleix Prat & Atanasio Pandiella. (2021) Modelling hypersensitivity to trastuzumab defines biomarkers of response in HER2 positive breast cancer. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Crossref
Alessandra Gentilini, Giulia Lori, Alessandra Caligiuri, Chiara Raggi, Giovanni Di Maira, Mirella Pastore, Benedetta Piombanti, Tiziano Lottini, Annarosa Arcangeli, Stefania Madiai, Nadia Navari, Jesus M. Banales, Sabina Di Matteo, Domenico Alvaro, Lea Duwe, Jesper B. Andersen, Alessandro Tubita, Ignazia Tusa, Luca Di Tommaso, Claudia Campani, Elisabetta Rovida & Fabio Marra. (2021) Extracellular Signal‐Regulated Kinase 5 Regulates the Malignant Phenotype of Cholangiocarcinoma Cells. Hepatology 74:4, pages 2007-2020.
Crossref
Crossref
Adrián Sánchez-Fdez, María Florencia Re-Louhau, Pablo Rodríguez-Núñez, Dolores Ludeña, Sofía Matilla-Almazán, Atanasio Pandiella & Azucena Esparís-Ogando. (2021) Clinical, genetic and pharmacological data support targeting the MEK5/ERK5 module in lung cancer. npj Precision Oncology 5:1.
Crossref
Crossref
Qiuping Xu, Jingwei Zhang, Brian A. Telfer, Hao Zhang, Nisha Ali, Fuhui Chen, Blanca Risa, Adam J. Pearson, Wei Zhang, Katherine G. Finegan, Ahmet Ucar, Emanuele Giurisato & Cathy Tournier. (2021) The extracellular-regulated protein kinase 5 (ERK5) enhances metastatic burden in triple-negative breast cancer through focal adhesion protein kinase (FAK)-mediated regulation of cell adhesion. Oncogene 40:23, pages 3929-3941.
Crossref
Crossref
Nilesh Malavia, Kaushik Kuche, Rohan Ghadi & Sanyog Jain. (2021) A bird's eye view of the advanced approaches and strategies for overshadowing triple negative breast cancer. Journal of Controlled Release 330, pages 72-100.
Crossref
Crossref
Juan Carlos Montero & Atanasio Pandiella. (2020) PDCD4 limits prooncogenic neuregulin-ErbB signaling. Cellular and Molecular Life Sciences 78:4, pages 1799-1815.
Crossref
Crossref
Christian Adam, Lorenza Fusi, Neele Weiss, Simon G. Goller, Katharina Meder, Verena G. Frings, Hermann Kneitz, Matthias Goebeler, Roland Houben, David Schrama & Marc Schmidt. (2020) Efficient Suppression of NRAS-Driven Melanoma by Co-Inhibition of ERK1/2 and ERK5 MAPK Pathways. Journal of Investigative Dermatology 140:12, pages 2455-2465.e10.
Crossref
Crossref
Diane M. Pereira & Cecília M.P. Rodrigues. (2020) Targeted Avenues for Cancer Treatment: The MEK5–ERK5 Signaling Pathway. Trends in Molecular Medicine 26:4, pages 394-407.
Crossref
Crossref
Alessandro Tubita, Zoe Lombardi, Ignazia Tusa, Persio Dello Sbarba & Elisabetta Rovida. (2020) Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy. International Journal of Molecular Sciences 21:3, pages 938.
Crossref
Crossref
Adam J. Pearson, Paul Fullwood, Gabriela Toro Tapia, Ian Prise, Michael P. Smith, Qiuping Xu, Allan Jordan, Emanuele Giurisato, Alan J. Whitmarsh, Chiara Francavilla & Cathy Tournier. (2020) Discovery of a Gatekeeper Residue in the C-Terminal Tail of the Extracellular Signal-Regulated Protein Kinase 5 (ERK5). International Journal of Molecular Sciences 21:3, pages 929.
Crossref
Crossref
Elena Díaz-Rodríguez, Javier Pérez-Peña, Carla Ríos-Luci, Joaquín Arribas, Alberto Ocaña & Atanasio Pandiella. (2019) TRAIL receptor activation overcomes resistance to trastuzumab in HER2 positive breast cancer cells. Cancer Letters 453, pages 34-44.
Crossref
Crossref
Celia Nieto, Ariana Centa, Jesús A. Rodríguez-Rodríguez, Atanasio Pandiella & Eva M. Martín del Valle. (2019) Paclitaxel-Trastuzumab Mixed Nanovehicle to Target HER2-Overexpressing Tumors. Nanomaterials 9:7, pages 948.
Crossref
Crossref
Lucía Benito-Jardón, Marta Díaz-Martínez, Nohemi Arellano-Sánchez, Paloma Vaquero-Morales, Azucena Esparís-Ogando & Joaquin Teixidó. (2019) Resistance to MAPK Inhibitors in Melanoma Involves Activation of the IGF1R–MEK5–Erk5 Pathway. Cancer Research 79:9, pages 2244-2256.
Crossref
Crossref
Chunyu Wu, Mingcang Chen, Qiuhua Zhang, Linghong Yu, Jiayan Zhu & Xiufei Gao. (2019) Genomic and GeneChip expression profiling reveals the inhibitory effects of Amorphophalli Rhizoma in TNBC cells. Journal of Ethnopharmacology 235, pages 206-218.
Crossref
Crossref
Adrián Sánchez-Fdez, María Jesús Ortiz-Ruiz, María Florencia Re-Louhau, Isabel Ramos, Óscar Blanco-Múñez, Dolores Ludeña, Mar Abad, Manuel Sánchez-Martín, Atanasio Pandiella & Azucena Esparís-Ogando. (2019) MEK5 promotes lung adenocarcinoma. European Respiratory Journal 53:2, pages 1801327.
Crossref
Crossref
Weiwei Jiang, Guanghui Jin, Fangfang Cai, Xiao Chen, Nini Cao, Xiangyu Zhang, Jia Liu, Fei Chen, Feng Wang, Wei Dong, Hongqin Zhuang & Zi-Chun Hua. (2019) Extracellular signal-regulated kinase 5 increases radioresistance of lung cancer cells by enhancing the DNA damage response. Experimental & Molecular Medicine 51:2, pages 1-20.
Crossref
Crossref
Duy Nguyen, Clara Lemos, Lars Wortmann, Knut Eis, Simon J. Holton, Ulf Boemer, Dieter Moosmayer, Uwe Eberspaecher, Joerg Weiske, Christian Lechner, Stefan Prechtl, Detlev Suelzle, Franziska Siegel, Florian Prinz, Ralf Lesche, Barbara Nicke, Katrin Nowak-Reppel, Herbert Himmel, Dominik Mumberg, Franz von Nussbaum, Carl F. Nising, Marcus Bauser & Andrea Haegebarth. (2018)
Discovery and Characterization of the Potent and Highly Selective (Piperidin-4-yl)pyrido[3,2-
d
]pyrimidine Based
in Vitro
Probe
BAY-885
for the Kinase ERK5
. Journal of Medicinal Chemistry 62:2, pages 928-940.
Crossref
Crossref
Angelina V. Vaseva, Devon R. Blake, Thomas S.K. Gilbert, Serina Ng, Galen Hostetter, Salma H. Azam, Irem Ozkan-Dagliyan, Prson Gautam, Kirsten L. Bryant, Kenneth H. Pearce, Laura E. Herring, Haiyong Han, Lee M. Graves, Agnieszka K. Witkiewicz, Erik S. Knudsen, Chad V. Pecot, Naim Rashid, Peter J. Houghton, Krister Wennerberg, Adrienne D. Cox & Channing J. Der. (2018) KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism. Cancer Cell 34:5, pages 807-822.e7.
Crossref
Crossref
Ignazia Tusa, Giulia Cheloni, Martina Poteti, Antonella Gozzini, Ngoc Ho DeSouza, Yi Shan, Xianming Deng, Nathanael S. Gray, Shaoguang Li, Elisabetta Rovida & Persio Dello Sbarba. (2018) Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells. Stem Cell Reports 11:4, pages 929-943.
Crossref
Crossref
Ariana Centa, Ruth Rodríguez‐Barrueco, Juan Carlos Montero & Atanasio Pandiella. (2018) The immunoglobulin‐like domain of neuregulins potentiates ErbB3/HER3 activation and cellular proliferation. Molecular Oncology 12:7, pages 1061-1076.
Crossref
Crossref
Ignazia Tusa, Sinforosa Gagliardi, Alessandro Tubita, Silvia Pandolfi, Carmelo Urso, Lorenzo Borgognoni, Jinhua Wang, Xianming Deng, Nathanael S Gray, Barbara Stecca & Elisabetta Rovida. (2018) ERK5 is activated by oncogenic BRAF and promotes melanoma growth. Oncogene 37:19, pages 2601-2614.
Crossref
Crossref
Nhat-Tu Le, Nguyet Minh Hoang, Keigi Fujiwara & Jun-ichi Abe. 2018. Encyclopedia of Signaling Molecules. Encyclopedia of Signaling Molecules
3052
3074
.
Ana Orive‐Ramos, Samuel Seoane, Alberto Ocaña, Atanasio Pandiella & Juan Carlos Montero. (2017)
Regulation of the prometastatic neuregulin–
MMP
13 axis by
SRC
family kinases: therapeutic implications
. Molecular Oncology 11:12, pages 1788-1805.
Crossref
Crossref
Xu Zhang, Tapan Maity, Manoj K. Kashyap, Mukesh Bansal, Abhilash Venugopalan, Sahib Singh, Shivangi Awasthi, Arivusudar Marimuthu, Harrys Kishore Charles Jacob, Natalya Belkina, Stephanie Pitts, Constance M. Cultraro, Shaojian Gao, Guldal Kirkali, Romi Biswas, Raghothama Chaerkady, Andrea Califano, Akhilesh Pandey & Udayan Guha. (2017) Quantitative Tyrosine Phosphoproteomics of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-treated Lung Adenocarcinoma Cells Reveals Potential Novel Biomarkers of Therapeutic Response. Molecular & Cellular Proteomics 16:5, pages 891-910.
Crossref
Crossref
Chengli Song, Lina Wang, Qiang Xu, Kai Wang, Dan Xie, Zhe Yu, Kui Jiang, Lujian Liao, John R. Yates, Jiing-Dwan Lee & Qingkai Yang. (2017) Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma. Scientific Reports 7:1.
Crossref
Crossref
Van T. Hoang, Thomas J. Yan, Jane E. Cavanaugh, Patrick T. Flaherty, Barbara S. Beckman & Matthew E. Burow. (2017) Oncogenic signaling of MEK5-ERK5. Cancer Letters 392, pages 51-59.
Crossref
Crossref
Anita K. Bakrania, Bhavesh C. Variya & Snehal S. Patel. (2016) Novel targets for paclitaxel nano formulations: Hopes and hypes in triple negative breast cancer. Pharmacological Research 111, pages 577-591.
Crossref
Crossref
Maria Tsioumpekou, Natalia Papadopoulos, Fatima Burovic, Carl-Henrik Heldin & Johan Lennartsson. (2016) Platelet-derived growth factor (PDGF)-induced activation of Erk5 MAP-kinase is dependent on Mekk2, Mek1/2, PKC and PI3-kinase, and affects BMP signaling. Cellular Signalling 28:9, pages 1422-1431.
Crossref
Crossref
Petrus R. de Jong, Koji Taniguchi, Alexandra R. Harris, Samuel Bertin, Naoki Takahashi, Jen Duong, Alejandro D. Campos, Garth Powis, Maripat Corr, Michael Karin & Eyal Raz. (2016) ERK5 signalling rescues intestinal epithelial turnover and tumour cell proliferation upon ERK1/2 abrogation. Nature Communications 7:1.
Crossref
Crossref
Logan FulfordDavid MilewskiVladimir UstiyanNavin RavishankarYuqi CaiTien LeSreeharsha MasineniSusan KasperBruce AronowVladimir V. KalinichenkoTanya V. Kalin. (2016) The transcription factor FOXF1 promotes prostate cancer by stimulating the mitogen-activated protein kinase ERK5. Science Signaling 9:427.
Crossref
Crossref
Hongming Chen, Julie Tucker, Xiaotao Wang, Paul R. Gavine, Chris Phillips, Martin A. Augustin, Patrick Schreiner, Stefan Steinbacher, Marian Preston & Derek Ogg. (2016) Discovery of a novel allosteric inhibitor-binding site in ERK5: comparison with the canonical kinase hinge ATP-binding site. Acta Crystallographica Section D Structural Biology 72:5, pages 682-693.
Crossref
Crossref
YING XIONG, LUYING ZHANG & TAO WANG. (2016) Phosphorylation of BMK1 induces prostatic carcinoma cell proliferation by promoting entry into the S phase of the cell cycle. Oncology Letters 11:1, pages 99-104.
Crossref
Crossref
Nhat-Tu Le, Nguyet Minh Hoang, Keigi Fujiwara & Jun-ichi Abe. 2016. Encyclopedia of Signaling Molecules. Encyclopedia of Signaling Molecules
1
23
.
Paul R. Gavine, Mei Wang, Dehua Yu, Eva Hu, Chunlei Huang, Jenny Xia, Xinying Su, Joan Fan, Tianwei Zhang, Qingqing Ye, Li Zheng, Guanshan Zhu, Ziliang Qian, Qingquan Luo, Ying Yong Hou & Qunsheng Ji. (2015) Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma. BMC Cancer 15:1.
Crossref
Crossref
Chengli Song, Qiang Xu, Kui Jiang, Guangyu Zhou, Xuebin Yu, Lina Wang, Yuting Zhu, Liping Fang, Zhe Yu, Jiing-Dwan Lee, Shi-Cang Yu & Qingkai Yang. (2015) Inhibition of BMK1 pathway suppresses cancer stem cells through BNIP3 and BNIP3L. Oncotarget 6:32, pages 33279-33289.
Crossref
Crossref
Kevin WilhelmsenFengyun XuKatherine FarrarAlphonso TranSamira KhakpourShirin SundarArun PrakashJinhua WangNathanael S. GrayJudith Hellman. (2015) Extracellular signal–regulated kinase 5 promotes acute cellular and systemic inflammation. Science Signaling 8:391.
Crossref
Crossref
Scott J. CameronSara K. TureDeanne MickelsenEnakshi ChakrabartiKristina L. ModjeskiScott McNittMichael SeaberryDavid J. FieldNhat-Tu LeJun-ichi AbeCraig N. Morrell. (2015) Platelet Extracellular Regulated Protein Kinase 5 Is a Redox Switch and Triggers Maladaptive Platelet Responses and Myocardial Infarct Expansion. Circulation 132:1, pages 47-58.
Crossref
Crossref
María Jesús Ortiz-Ruiz, Stela Álvarez-Fernández, Tracy Parrott, Sara Zaknoen, Francis J. Burrows, Alberto Ocaña, Atanasio Pandiella & Azucena Esparís-Ogando. (2014) Therapeutic potential of ERK5 targeting in triple negative breast cancer. Oncotarget 5:22, pages 11308-11318.
Crossref
Crossref
Xuening Wang, Stella Pesakhov, Jonathan S. Harrison, Michael Danilenko & George P. Studzinski. (2014) ERK5 Pathway Regulates Transcription Factors Important for Monocytic Differentiation of Human Myeloid Leukemia Cells. Journal of Cellular Physiology 229:7, pages 856-867.
Crossref
Crossref
Fares Al-Ejeh, Mariska Miranda, Wei Shi, Peter T. Simpson, Sarah Song, Ana Cristina Vargas, Jodi M. Saunus, Chanel E. Smart, Mythily Mariasegaram, Adrian P. Wiegmans, Georgia Chenevix-Trench, Sunil R. Lakhani & Kum Kum Khanna. (2014) Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer. Oncotarget 5:10, pages 3145-3158.
Crossref
Crossref
Mayur S. Parmar, Juliann D. Jaumotte, Stephanie L. Wyrostek, Michael J. Zigmond & Jane E. Cavanaugh. (2014) The role of ERK1, 2, and 5 in dopamine neuron survival during aging. Neurobiology of Aging 35:3, pages 669-679.
Crossref
Crossref
Andrej Gorbatenko, Christina W. Olesen, Nina M⊘rup, Gerald Thiel, Tuula Kallunki, Eivind Valen & Stine F. Pedersen. (2013)
ErbB2 upregulates the Na
+
,HCO
3
‐
‐cotransporter NBCn1/
SLC4A7
in human breast cancer cells
via
Akt, ERK, Src, and Krüppel‐like factor 4
. The FASEB Journal 28:1, pages 350-363.
Crossref
Crossref
Akintunde Akinleye, Muhammad Furqan, Nikhil Mukhi, Pavan Ravella & Delong Liu. (2013) MEK and the inhibitors: from bench to bedside. Journal of Hematology & Oncology 6:1.
Crossref
Crossref
Sarah J. MalmquistAlexandra AbramssonHillary F. McGrawTor H. LinboDavid W. Raible. (2013) Modulation of dorsal root ganglion development by ErbB signaling and the scaffold protein Sorbs3. Development 140:19, pages 3986-3996.
Crossref
Crossref
José Ángel García-Pedraza, Mónica García, María Luisa Martín, Jesús Gómez-Escudero, Alicia Rodríguez-Barbero, Luis San Román & Asunción Morán. (2013) Peripheral 5-HT1D and 5-HT7 serotonergic receptors modulate sympathetic neurotransmission in chronic sarpogrelate treated rats. European Journal of Pharmacology 714:1-3, pages 65-73.
Crossref
Crossref
Q Yang, L Liao, X Deng, R Chen, N S Gray, J R YatesIIIIII & J D Lee. (2012) BMK1 is involved in the regulation of p53 through disrupting the PML–MDM2 interaction. Oncogene 32:26, pages 3156-3164.
Crossref
Crossref
Stela Álvarez-Fernández, María Jesús Ortiz-Ruiz, Tracy Parrott, Sara Zaknoen, Enrique M. Ocio, Jesús San Miguel, Francis J. Burrows, Azucena Esparís-Ogando & Atanasio Pandiella. (2013) Potent Antimyeloma Activity of a Novel ERK5/CDK Inhibitor. Clinical Cancer Research 19:10, pages 2677-2687.
Crossref
Crossref
Emily K. RedmanPaul S. BrookesMarcin K. Karcz. (2013) Role of p90RSK in regulating the Crabtree effect: implications for cancer. Biochemical Society Transactions 41:1, pages 124-126.
Crossref
Crossref
Bang Hu, Donglin Ren, Dan Su, Hongcheng Lin, Zhenyu Xian, Xingyang Wan, Junxiao Zhang, Xinhui Fu, Li Jiang, Dechan Diao, Xinjuan Fan, Lei Wang & Jianping Wang. (2012) Expression of the phosphorylated MEK5 protein is associated with TNM staging of colorectal cancer. BMC Cancer 12:1.
Crossref
Crossref
Diana Perez-Madrigal, Katherine G. Finegan, Blanca Paramo & Cathy Tournier. (2012) The extracellular-regulated protein kinase 5 (ERK5) promotes cell proliferation through the down-regulation of inhibitors of cyclin dependent protein kinases (CDKs). Cellular Signalling 24:12, pages 2360-2368.
Crossref
Crossref
Gopika N. Nithianandarajah-Jones, Bettina Wilm, Christopher E.P. Goldring, Jürgen Müller & Michael J. Cross. (2012) ERK5: Structure, regulation and function. Cellular Signalling 24:11, pages 2187-2196.
Crossref
Crossref
Junhui Zou, Yung-Wei Pan, Zhenshan Wang, Shih-Yu Chang, Wenbin Wang, Xin Wang, Cathy Tournier, Daniel R. Storm & Zhengui Xia. (2012) Targeted Deletion of ERK5 MAP Kinase in the Developing Nervous System Impairs Development of GABAergic Interneurons in the Main Olfactory Bulb and Behavioral Discrimination between Structurally Similar Odorants. The Journal of Neuroscience 32:12, pages 4118-4132.
Crossref
Crossref
Pamela A. LochheadRebecca GilleySimon J. Cook. (2012) ERK5 and its role in tumour development. Biochemical Society Transactions 40:1, pages 251-256.
Crossref
Crossref
Barbara A. Drew, Matthew E. Burow & Barbara S. Beckman. (2012) MEK5/ERK5 pathway: The first fifteen years. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1825:1, pages 37-48.
Crossref
Crossref
Konstantina Katsarou, Panagiota Tsitoura & Urania Georgopoulou. (2011) MEK5/ERK5/mef2: A novel signaling pathway affected by hepatitis C virus non-enveloped capsid-like particles. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1813:10, pages 1854-1862.
Crossref
Crossref
Ujendra Kumar. (2011) Cross-talk and modulation of signaling between somatostatin and growth factor receptors. Endocrine 40:2, pages 168-180.
Crossref
Crossref
Weina Jin, Qinghua Li, Yani Lin, Ying Lu, Huawen Li, Lihong Wang, Ronghua Hu, Li Ma, Jianxiang Wang & Tianxiang Pang. (2011) Reversal of Imatinib resistance in BCR-ABL-positive leukemia after inhibition of the Na+/H+ exchanger. Cancer Letters 308:1, pages 81-90.
Crossref
Crossref
Juan Carlos Montero, Ruth Rodríguez-Barrueco & Atanasio Pandiella. (2011) Transautocrine Signaling by Membrane Neuregulins Requires Cell Surface Targeting, Which Is Controlled by Multiple Domains. Journal of Biological Chemistry 286:27, pages 24350-24363.
Crossref
Crossref
Qingkai Yang & Jiing-Dwan Lee. (2011) Targeting the BMK1 MAP Kinase Pathway in Cancer Therapy. Clinical Cancer Research 17:11, pages 3527-3532.
Crossref
Crossref
Geetanjali Kharmate, Padmesh S. Rajput, Heather L. Watt, Rishi K. Somvanshi, Nicole Chaudhari, Xiaofan Qiu & Ujendra Kumar. (2011) Role of somatostatin receptor 1 and 5 on epidermal growth factor receptor mediated signaling. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1813:6, pages 1172-1189.
Crossref
Crossref
Vera Barra, Anne-Marie Kuhn, Andreas von Knethen, Andreas Weigert & Bernhard Brüne. (2010) Apoptotic cell-derived factors induce arginase II expression in murine macrophages by activating ERK5/CREB. Cellular and Molecular Life Sciences 68:10, pages 1815-1827.
Crossref
Crossref
Xianming Deng, Qingkai Yang, Nicholas Kwiatkowski, Taebo Sim, Ultan McDermott, Jeffrey E. Settleman, Jiing-Dwan Lee & Nathanael S. Gray. (2011) Discovery of a benzo[e]pyrimido-[5,4-b][1,4]diazepin-6(11H)-one as a Potent and Selective Inhibitor of Big MAP Kinase 1. ACS Medicinal Chemistry Letters 2:3, pages 195-200.
Crossref
Crossref
J C Montero, S Seoane, A Ocaña & A Pandiella. (2010) P-Rex1 participates in Neuregulin-ErbB signal transduction and its expression correlates with patient outcome in breast cancer. Oncogene 30:9, pages 1059-1071.
Crossref
Crossref
Geetanjali Kharmate, Padmesh S. Rajput, Heather L. Watt, Rishi K. Somvanshi, Nicole Chaudhari, Xiaofan Qiu & Ujendra Kumar. (2011) Dissociation of Epidermal Growth Factor Receptor and ErbB2 Heterodimers in the Presence of Somatostatin Receptor 5 Modulate Signaling Pathways. Endocrinology 152:3, pages 931-945.
Crossref
Crossref
Francisco A. Iñesta-Vaquera, David G. Campbell, Cathy Tournier, Nestor Gómez, Jose M. Lizcano & A. Cuenda. (2010) Alternative ERK5 regulation by phosphorylation during the cell cycle. Cellular Signalling 22:12, pages 1829-1837.
Crossref
Crossref
Samuel Seoane, Juan Carlos Montero, Alberto Ocaña & Atanasio Pandiella. (2010) Effect of Multikinase Inhibitors on Caspase-Independent Cell Death and DNA Damage in HER2-Overexpressing Breast Cancer Cells. JNCI: Journal of the National Cancer Institute 102:18, pages 1432-1446.
Crossref
Crossref
Elena DÍaz-RodrÍguez & Atanasio Pandiella. (2010) Multisite phosphorylation of Erk5 in mitosis. Journal of Cell Science 123:18, pages 3146-3156.
Crossref
Crossref
Qingkai Yang, Xianming Deng, Bingwen Lu, Michael Cameron, Colleen Fearns, Matthew P. Patricelli, John R. YatesIIIIII, Nathanael S. Gray & Jiing-Dwan Lee. (2010) Pharmacological Inhibition of BMK1 Suppresses Tumor Growth through Promyelocytic Leukemia Protein. Cancer Cell 18:3, pages 258-267.
Crossref
Crossref
Nancy E Castro & Carol A Lange. (2010) Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells. Breast Cancer Research 12:4.
Crossref
Crossref
Prem Khanal, Gwang Mo Namgoong, Bong Seok Kang, Eun-Rhan Woo & Hong Seok Choi. (2010) The Prolyl Isomerase Pin1 Enhances HER-2 Expression and Cellular Transformation via Its Interaction with Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase 1. Molecular Cancer Therapeutics 9:3, pages 606-616.
Crossref
Crossref
T.S. Karin Eisinger-Mathason, Josefa Andrade & Deborah A. Lannigan. (2010) RSK in tumorigenesis: Connections to steroid signaling. Steroids 75:3, pages 191-202.
Crossref
Crossref
Aaron T. Charlson, Nicholette A. Zeliadt & Elizabeth V. Wattenberg. (2009) Extracellular signal regulated kinase 5 mediates signals triggered by the novel tumor promoter palytoxin. Toxicology and Applied Pharmacology 241:2, pages 143-153.
Crossref
Crossref
Jacqueline Whyte, Orla Bergin, Alessandro Bianchi, Sara McNally & Finian Martin. (2009) Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development. Breast Cancer Research 11:5.
Crossref
Crossref
Asunción Morán, Ana-Vega Ortiz de Urbina, María-Luisa Martín, Alicia Rodríguez-Barbero & Luis San Román. (2009) Characterization of the contractile 5-hydroxytryptamine receptor in the autoperfused kidney of L-NAME hypertensive rats. European Journal of Pharmacology 620:1-3, pages 90-96.
Crossref
Crossref
Guillermo Bodega, Sergio Ciordia, Isabel Suárez, Luis Andrés López-Fernández, Enrique Vacas, Gonzalo Sánchez-Tejeda, María Amparo Albert, Silvia Juárez, Juan Pablo Albar & Benjamín Fernández. (2009) Astrocytes express Mxi2, a splice isoform of p38MAPK. Journal of Molecular Histology 40:5-6, pages 325-329.
Crossref
Crossref
Rebecca Gilley, H. Nikki March & Simon J. Cook. (2009) ERK1/2, but not ERK5, is necessary and sufficient for phosphorylation and activation of c-Fos. Cellular Signalling 21:6, pages 969-977.
Crossref
Crossref
Juan Carlos Montero, Alberto Ocaña, Mar Abad, María Jesús Ortiz-Ruiz, Atanasio Pandiella & Azucena Esparís-Ogando. (2009) Expression of Erk5 in Early Stage Breast Cancer and Association with Disease Free Survival Identifies this Kinase as a Potential Therapeutic Target. PLoS ONE 4:5, pages e5565.
Crossref
Crossref
Keika Zen, Kohichiroh Yasui, Tomoaki Nakajima, Yoh Zen, Kan Zen, Yasuyuki Gen, Hironori Mitsuyoshi, Masahito Minami, Shoji Mitsufuji, Shinji Tanaka, Yoshito Itoh, Yasuni Nakanuma, Masafumi Taniwaki, Shigeki Arii, Takeshi Okanoue & Toshikazu Yoshikawa. (2009) ERK5 is a target for gene amplification at 17p11 and promotes cell growth in hepatocellular carcinoma by regulating mitotic entry. Genes, Chromosomes and Cancer 48:2, pages 109-120.
Crossref
Crossref
María D. Carretta, Pablo Alarcón, Evelyn Jara, Loreto Solis, Juan L. Hancke, Ilona I. Concha, María A. Hidalgo & Rafael A. Burgos. (2009) Andrographolide reduces IL-2 production in T-cells by interfering with NFAT and MAPK activation. European Journal of Pharmacology 602:2-3, pages 413-421.
Crossref
Crossref
Shuping Fang, Jin Fu, Xia Yuan, Cui Han, Lijun Shi, Yinqiang Xin, Lan Luo & Zhimin Yin. (2009) Heat shock protein 90 regulates the stability of MEKK3 in HEK293 cells. Cellular Immunology 259:1, pages 49-55.
Crossref
Crossref
Y.-J. J. Chen, L. W. Role & D. A. Talmage. 2009. Handbook of Neurochemistry and Molecular Neurobiology. Handbook of Neurochemistry and Molecular Neurobiology
243
265
.
Vered Levin-Salomon, Konstantin Kogan, Natalie G. Ahn, Oded Livnah & David Engelberg. (2008) Isolation of Intrinsically Active (MEK-independent) Variants of the ERK Family of Mitogen-activated Protein (MAP) Kinases. Journal of Biological Chemistry 283:50, pages 34500-34510.
Crossref
Crossref
F. Dorado, S. Velasco, A. Esparis-Ogando, M. Pericacho, A. Pandiella, J. Silva, J. M. Lopez-Novoa & A. Rodriguez-Barbero. (2008) The mitogen-activated protein kinase Erk5 mediates human mesangial cell activation. Nephrology Dialysis Transplantation 23:11, pages 3403-3411.
Crossref
Crossref
A. Esparís-Ogando, A. Ocaña, R. Rodríguez-Barrueco, L. Ferreira, J. Borges & A. Pandiella. (2008) Synergic antitumoral effect of an IGF-IR inhibitor and trastuzumab on HER2-overexpressing breast cancer cells. Annals of Oncology 19:11, pages 1860-1869.
Crossref
Crossref
Alessandra Marchetti, Marta Colletti, Angela Maria Cozzolino, Corinna Steindler, Mario Lunadei, Carmine Mancone & Marco Tripodi. (2008) ERK5/MAPK is activated by TGFβ in hepatocytes and required for the GSK-3β-mediated Snail protein stabilization. Cellular Signalling 20:11, pages 2113-2118.
Crossref
Crossref
Asunción Morán, Ana-Vega Ortiz de Urbina, Maria-Luisa Martín, Mónica García, Alicia Rodriguez-Barbero, Fernando Dorado & Luis San Román. (2008) Characterization of contractile 5-hydroxytryptamine receptor subtypes in the in situ autoperfused kidney in the anaesthetized rat. European Journal of Pharmacology 592:1-3, pages 133-137.
Crossref
Crossref
Rebecca S. Arkell, Robin J. Dickinson, Matthew Squires, Shaista Hayat, Stephen M. Keyse & Simon J. Cook. (2008) DUSP6/MKP-3 inactivates ERK1/2 but fails to bind and inactivate ERK5. Cellular Signalling 20:5, pages 836-843.
Crossref
Crossref
Mao Ye, Xiangjian Luo, Lili Li, Ying Shi, Ming Tan, Xinxian Weng, Wei Li, Jikai Liu & Ya Cao. (2007) Grifolin, a potential antitumor natural product from the mushroom Albatrellus confluens, induces cell-cycle arrest in G1 phase via the ERK1/2 pathway. Cancer Letters 258:2, pages 199-207.
Crossref
Crossref
Emma Villa-Moruzzi. (2007) Targeting of FAK Ser910 by ERK5 and PP1δ in non-stimulated and phorbol ester-stimulated cells. Biochemical Journal 408:1, pages 7-18.
Crossref
Crossref
Ana Gírio, Juan Carlos Montero, Atanasio Pandiella & Sukalyan Chatterjee. (2007) Erk5 is activated and acts as a survival factor in mitosis. Cellular Signalling 19:9, pages 1964-1972.
Crossref
Crossref
Julie Hanson Ostrander, Andrea R. Daniel, Kristopher Lofgren, Celina G. Kleer & Carol A. Lange. (2007) Breast Tumor Kinase (Protein Tyrosine Kinase 6) Regulates Heregulin-Induced Activation of ERK5 and p38 MAP Kinases in Breast Cancer Cells. Cancer Research 67:9, pages 4199-4209.
Crossref
Crossref
Kelly Cude, Yupeng Wang, Hyun-Jung Choi, Shih-Ling Hsuan, Honglai Zhang, Cun-Yu Wang & Zhengui Xia. (2007) Regulation of the G2–M cell cycle progression by the ERK5–NFκB signaling pathway. Journal of Cell Biology 177:2, pages 253-264.
Crossref
Crossref
Rita Sarközi, Bradley Miller, Verena Pollack, Elisabeth Feifel, Gert Mayer, Andrey Sorokin & Herbert Schramek. (2007) ERK1/2-driven and MKP-mediated inhibition of EGF-induced ERK5 signaling in human proximal tubular cells. Journal of Cellular Physiology 211:1, pages 88-100.
Crossref
Crossref
Berta Casar, Victoria Sanz-Moreno, Mustafa N Yazicioglu, Javier Rodríguez, María T Berciano, Miguel Lafarga, Melanie H Cobb & Piero Crespo. (2007) Mxi2 promotes stimulus-independent ERK nuclear translocation. The EMBO Journal 26:3, pages 635-646.
Crossref
Crossref
Juan C. Montero, Ruth Rodríguez-Barrueco, Laura Yuste, Pedro P. Juanes, Joana Borges, Azucena Esparís-Ogando & Atanasio Pandiella. (2007) The Extracellular Linker of pro-Neuregulin-α2c Is Required for Efficient Sorting and Juxtacrine Function. Molecular Biology of the Cell 18:2, pages 380-393.
Crossref
Crossref
Johan Garaude, Seyma Cherni, Sandra Kaminski, Etienne Delepine, Christine Chable-Bessia, Monsef Benkirane, Joana Borges, Atanasio Pandiella, Miguel Angel Iñiguez, Manuel Fresno, Robert A. Hipskind & Martin Villalba. (2006) ERK5 Activates NF-κB in Leukemic T Cells and Is Essential for Their Growth In Vivo. The Journal of Immunology 177:11, pages 7607-7617.
Crossref
Crossref
Satoko Nishimoto & Eisuke Nishida. (2006) MAPK signalling: ERK5 versus ERK1/2. EMBO reports 7:8, pages 782-786.
Crossref
Crossref
Yan Wu, André Kajdacsy-Balla, Estil Strawn, Zainab Basir, Gloria Halverson, Parthav Jailwala, Yuedong Wang, Xujing Wang, Soumitra Ghosh & Sun-Wei Guo. (2006) Transcriptional Characterizations of Differences between Eutopic and Ectopic Endometrium. Endocrinology 147:1, pages 232-246.
Crossref
Crossref
J. Garaude, S. Kaminski, S. Cherni, R. A. Hipskind & M. Villalba. (2005) The Role of ERK5 in T-Cell Signalling. Scandinavian Journal of Immunology 62:6, pages 515-520.
Crossref
Crossref
Masaaki Hayashi, Colleen Fearns, Brian Eliceiri, Young Yang & Jiing-Dwan Lee. (2005) Big Mitogen-Activated Protein Kinase 1/Extracellular Signal-Regulated Kinase 5 Signaling Pathway Is Essential for Tumor-Associated Angiogenesis. Cancer Research 65:17, pages 7699-7706.
Crossref
Crossref
Maureen O. Ripple, Sahana Kalmadi & Alan Eastman. (2005) Inhibition of Either Phosphatidylinositol 3-kinase/Akt or the Mitogen/Extracellular-regulated Kinase, MEK/ERK, Signaling Pathways Suppress Growth of Breast Cancer Cell Lines, but MEK/ERK Signaling is Critical for Cell Survival. Breast Cancer Research and Treatment 93:2, pages 177-188.
Crossref
Crossref
Laura Yuste, Juan C. Montero, Azucena Esparís-Ogando & Atanasio Pandiella. (2005) Activation of ErbB2 by Overexpression or by Transmembrane Neuregulin Results in Differential Signaling and Sensitivity to Herceptin. Cancer Research 65:15, pages 6801-6810.
Crossref
Crossref
Lisa-Marie Sturla, Christopher W. Cowan, Lillian Guenther, Robert C. Castellino, John Y.H. Kim & Scott L. Pomeroy. (2005) A Novel Role for Extracellular Signal-Regulated Kinase 5 and Myocyte Enhancer Factor 2 in Medulloblastoma Cell Death. Cancer Research 65:13, pages 5683-5689.
Crossref
Crossref
Kunio Kondoh, Satoru Torii & Eisuke Nishida. (2005) Control of MAP kinase signaling to the nucleus. Chromosoma 114:2, pages 86-91.
Crossref
Crossref
Xonia Carvajal-VergaraSoraya TaberaJuan C. MonteroAzucena Esparís-OgandoRicardo López-PérezGema MateoNorma GutiérrezMarisa Parmo-CabañasJoaquín TeixidóJesús F. San MiguelAtanasio Pandiella. (2005) Multifunctional role of Erk5 in multiple myeloma. Blood 105:11, pages 4492-4499.
Crossref
Crossref
Laura Yuste, Azucena Esparís-Ogando, Eugenio Santos & Atanasio Pandiella. (2005) Overexpression of RasN17 Fails to Neutralize Endogenous Ras in MCF7 Breast Cancer Cells. The Journal of Biochemistry 137:6, pages 731-739.
Crossref
Crossref
Lili Wang, Jian Ma, Jiang Li, Xiaoling Li, Qiuhong Zhang, Shuping Peng, Cong Peng, Ming Zhou, Wei Xiong, Jianbo Yang, Jie Zhou, Songqing Fan, Chen Tan, Qun Yan, Shourong Shen & Guiyuan Li. (2005) NGX6 gene inhibits cell proliferation and plays a negative role in EGFR pathway in nasopharyngeal carcinoma cells. Journal of Cellular Biochemistry 95:1, pages 64-73.
Crossref
Crossref
Azucena Esparís-Ogando, Adrián Alegre, Beatriz Aguado, Gema Mateo, Norma Gutiérrez, Joan Bladé, David Schenkein, Atanasio Pandiella & Jesús F. San Miguel. (2005) Bortezomib is an efficient agent in plasma cell leukemias. International Journal of Cancer 114:4, pages 665-667.
Crossref
Crossref
Joana Castro Barros & Christopher J. Marshall. (2005) Activation of either ERK1/2 or ERK5 MAP kinase pathways can lead to disruption of the actin cytoskeleton. Journal of Cell Science 118:8, pages 1663-1671.
Crossref
Crossref
Asish K. Ghosh, Robert Steele & Ratna B. Ray. (2005) c-myc Promoter-binding Protein 1 (MBP-1) Regulates Prostate Cancer Cell Growth by Inhibiting MAPK Pathway. Journal of Biological Chemistry 280:14, pages 14325-14330.
Crossref
Crossref
Andrew Fire & Marshall NirenbergMaria E. Ramos-Nino & Brooke T. Mossman. 2009. RNA Interference Technology. RNA Interference Technology
447
469
.
Marcus Buschbeck & Axel Ullrich. (2005) The Unique C-terminal Tail of the Mitogen-activated Protein Kinase ERK5 Regulates Its Activation and Nuclear Shuttling. Journal of Biological Chemistry 280:4, pages 2659-2667.
Crossref
Crossref
Marie A. Bogoyevitch & Naomi W. Court. (2004) Counting on mitogen-activated protein kinases—ERKs 3, 4, 5, 6, 7 and 8. Cellular Signalling 16:12, pages 1345-1354.
Crossref
Crossref
Masaaki Hayashi & Jiing-Dwan Lee. (2004) Role of the BMK1/ERK5 signaling pathway: lessons from knockout mice. Journal of Molecular Medicine 82:12, pages 800-808.
Crossref
Crossref
Sung-Woo Kim, Ta-Hsiang Chao, Rong Xiang, Jeng-Fan Lo, Michael J. Campbell, Colleen Fearns & Jiing-Dwan Lee. (2004)
Tid1, the Human Homologue of a
Drosophila
Tumor Suppressor, Reduces the Malignant Activity of ErbB-2 in Carcinoma Cells
. Cancer Research 64:21, pages 7732-7739.
Crossref
Crossref
Debajit K. Biswas, Qian Shi, Shanon Baily, Ian Strickland, Sankar Ghosh, Arthur B. Pardee & J. Dirk Iglehart. (2004) NF-κB activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proceedings of the National Academy of Sciences 101:27, pages 10137-10142.
Crossref
Crossref
Jaideep V. Thottassery, Yanjie Sun, Louise Westbrook, Sarah S. Rentz, Marina Manuvakhova, Zhican Qu, Shanti Samuel, Ramanda Upshaw, Amanda Cunningham & Francis G. Kern. (2004) Prolonged Extracellular Signal-Regulated Kinase 1/2 Activation during Fibroblast Growth Factor 1- or Heregulin β1-Induced Antiestrogen-Resistant Growth of Breast Cancer Cells Is Resistant to Mitogen-Activated Protein/Extracellular Regulated Kinase Kinase Inhibitors. Cancer Research 64:13, pages 4637-4647.
Crossref
Crossref
Ziv Raviv, Eyal Kalie & Rony Seger. (2004) MEK5 and ERK5 are localized in the nuclei of resting as well as stimulated cells, while MEKK2 translocates from the cytosol to the nucleus upon stimulation. Journal of Cell Science 117:9, pages 1773-1784.
Crossref
Crossref
Luca Scapoli, Maria E Ramos-Nino, Marcella Martinelli & Brooke T Mossman. (2004) Src-dependent ERK5 and Src/EGFR-dependent ERK1/2 activation is required for cell proliferation by asbestos. Oncogene 23:3, pages 805-813.
Crossref
Crossref
Scott J. Cameron, Jun-ichi Abe, Sundeep Malik, Wenyi Che & Jay Yang. (2004) Differential Role of MEK5α and MEK5β in BMK1/ERK5 Activation. Journal of Biological Chemistry 279:2, pages 1506-1512.
Crossref
Crossref
Lijun Yan, Julia Carr, Peter R Ashby, Victoria Murry-Tait, Calum Thompson & J Simon C Arthur. (2003) Knockout of ERK5 causes multiple defects in placental and embryonic development. BMC Developmental Biology 3:1.
Crossref
Crossref
Roseann Mulloy, Sara Salinas, Alexandre Philips & Robert A Hipskind. (2003) Activation of cyclin D1 expression by the ERK5 cascade. Oncogene 22:35, pages 5387-5398.
Crossref
Crossref
Eric J. HuangLouis F. Reichardt. (2003) Trk Receptors: Roles in Neuronal Signal Transduction. Annual Review of Biochemistry 72:1, pages 609-642.
Crossref
Crossref
P B Mehta, B L Jenkins, L McCarthy, L Thilak, C N Robson, D E Neal & H Y Leung. (2003) MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion. Oncogene 22:9, pages 1381-1389.
Crossref
Crossref
Sue J. Sohn, Brieana K. Sarvis, Dragana Cado & Astar Winoto. (2002) ERK5 MAPK Regulates Embryonic Angiogenesis and Acts as a Hypoxia-sensitive Repressor of Vascular Endothelial Growth Factor Expression. Journal of Biological Chemistry 277:45, pages 43344-43351.
Crossref
Crossref
Marcus Buschbeck, Jan Eickhoff, Marc N. Sommer & Axel Ullrich. (2002) Phosphotyrosine-specific Phosphatase PTP-SL Regulates the ERK5 Signaling Pathway. Journal of Biological Chemistry 277:33, pages 29503-29509.
Crossref
Crossref